Pomalidomide-C8-COOH is a synthetic E3 ligase ligand-linker conjugate that incorporates Pomalidomide-based CRBN ligands and linkers used in PROTAC technology.
Structure of 2305936-70-1
* For research and manufacturing use only. Not for human or clinical use.
| Size | Price | Stock | Quantity |
|---|---|---|---|
| -- | $-- | In stock |
Looking for different specifications? Click to request a custom quote!
Capabilities & Facilities
Popular Publications Citing BOC Sciences Products
The Pomalidomide-C8-COOH E3 Ligase Ligand-Linker Conjugate is a crucial component in the development of PROTACs, facilitating targeted protein degradation by linking an E3 ligase ligand to a target protein ligand. This molecule offers enhanced specificity and efficacy in protein degradation research. The following provides a detailed description of this molecule.
Linker: The linker in this molecule is an 8-carbon aliphatic chain, providing moderate flexibility to accommodate diverse spatial orientations. Its non-cleavable nature ensures the stability of the conjugate, making it suitable for applications requiring sustained interaction between the ligase and the target protein.
Ligand: The ligand is derived from pomalidomide, a thalidomide analog known for its high affinity to the cereblon E3 ligase. Its structural characteristics include a glutarimide ring, which is essential for binding to the E3 ligase, facilitating the recruitment of the ubiquitin-proteasome system.
Reactive Site: The reactive site features a carboxylic acid group, which can couple with amine-containing target protein ligands through amide bond formation. This reaction type is favored for its stability and compatibility with aqueous environments, enabling efficient conjugation under physiological conditions.
Recommended Target Protein Ligand: The recommended warhead for this molecule is an amine-containing moiety, such as those found in lysine residues. This choice offers the advantage of forming stable amide bonds, ensuring robust target engagement. Applications include the development of PROTACs for the selective degradation of proteins implicated in various diseases, enhancing therapeutic research possibilities.
* Our calculator is based on the following equation:
Concentration (start) x Volume (start) = Concentration (final) x Volume (final)
It is commonly abbreviated as: C1V1 = C2V2
Please contact us with any specific requirements and we will get back to you as soon as possible.